Rat mesentery angiogenesis assay

Journal of Visualized Experiments

Volumn , Issue 52, 2011, Pages

  Norrby, Klas C ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80355129687     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/3078     Document Type: Article

References (12)

1. Norrby, K. In vivo models of angiogenesis. J. Cell. Mol. Med. 10, 588-612 (2006).
2. Norrby, K. Drug testing with angiogenesis models. Expert Opin. Drug. Discov. 3, 533-549 (2008).
3. Norrby, K., Jakobsson, A., & Sorbo, J. Mast-cell-mediated angiogenesis: a novel experimental model using the rat mesentery. Virchows Arch. B Cell. Pathol. Incl. Mol. Pathol. 52, 195-206 (1986).
4. Norrby, K. Mast cells and angiogenesis. APMIS 110, 355-371 (2002).
5. Albertsson, P., Lennernas, B., & Norrby, K. On meteronomic chemotherapy: modulation of angiogenesis mediated by VEGF-A. Acta Oncol. 45, 144-155 (2006).
6. Norrby, K. Human apo-lactoferrin enhances angiogenesis mediated by vascular endothelial growth factor A in vivo. J. Vasc. Res. 41, 293-304 (2004).
7. Norrby, K., Mattsby-Baltzer, I., Innocenti, M., & Tuneberg, S. Orally administered bovine lactoferrin systemically inhibits VEGF(165)-mediated angiogenesis in the rat. Int. J. Cancer 91, 236-240 (2001).
8. Norrby, K. Low-molecular-weight heparins and angiogenesis. APMIS 114, 79-102 (2006).
9. Norrby, K., & Nordenhem, A. Dalteparin. a low-molecular-weight heparin, promotes angiogenesis mediated by heparin-binding VEGF-A in vivo. APMIS 118, 949-957 (2010).
10. Norrby, K. Basic fibroblast growth factor and de novo mammalian angiogenesis. Microvasc. Res.48, 96-113 (1994).
11. Norrby, K. Vascular endothelial growth factor and de novo mammalian angiogenesis. Microvasc. Res. 51, 153-163 (1996).
12. Norrby, K. Microvascular density in terms of number and length of microvessel segments per unit tissue volume in mammalian angiogenesis. Microvasc. Res. 55, 43-53 (1998).